ShareCafe Investor Webinar Presentation
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases is pleased to announce its participation in the ShareCafe Small Cap “Hidden Gems” Webinar, to be held Friday 10th of March 2023 from 12:30pm AEDT/ 9:30am AWST.
Dr David Stamler – CEO will provide an overview of the Company which is a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases.
This webinar can be viewed live via Zoom and will provide viewers the opportunity to hear from, and engage with, a range of ASX-listed leading micro/mid cap companies.
To access further details of the event and to register at no cost, please copy and paste the following link into your internet browser:
A recorded copy of the webinar will be made available following the event.
About Alterity Therapeutics Limited
Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company’s lead asset, ATH434, has the potential to treat various Parkinsonian disorders. Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company’s web site at www.alteritytherapeutics.com.
Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.